Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.37 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | F2R | P25116 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PTGES | O14684 | 2/20 | 0.36 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16711984 | 1.00 | LMNA (0.41) | LMNAGAAALDH1A1MAPTMAPK1 | |
| SCHEMBL16712040 | 0.90 | ALDH1A1 (0.43) | LMNAGAAALDH1A1MAPTKCNK3 | |
| SCHEMBL16712042 | 0.90 | ALDH1A1 (0.43) | LMNAGAAALDH1A1MAPTKCNK3 | |
| SCHEMBL16711893 | 0.89 | HPGD (0.48) | LMNAGAAALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL16711891 | 0.89 | HPGD (0.48) | LMNAGAAALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL16711814 | 0.89 | CYP1A2 (0.43) | LMNAGAAALDH1A1MAPTMAPK1 | |
| SCHEMBL16711992 | 0.89 | CYP1A2 (0.43) | LMNAGAAALDH1A1MAPTMAPK1 | |
| SCHEMBL16711816 | 0.89 | CYP1A2 (0.43) | LMNAGAAALDH1A1MAPTMAPK1 | |
| SCHEMBL16711869 | 0.86 | KCNK3 (0.39) | LMNAGAAALDH1A1KCNK3KCNK9 | |
| SCHEMBL16711867 | 0.86 | KCNK3 (0.39) | LMNAGAAALDH1A1KCNK3KCNK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2873658-B1 | OXIME-SUBSTITUTED AMIDE COMPOUND AND PEST CONTROL AGENT | NISSAN CHEMICAL IND LTD (JP) | 2018-09-05 | — | — | EP | disclosed |
| US-9920046-B2 | Oxime-substituted amide compound and pest control agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-03-20 | — | — | US | disclosed |
| US-20160318919-A1 | OXIME-SUBSTITUTED AMIDE COMPOUND AND PEST CONTROL AGENT | NISSAN CHEMICAL INDUSTRIES, LTD (JP) | 2016-11-03 | — | — | US | disclosed |
| US-9434684-B2 | Oxime-substituted amide compound and pest control agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-09-06 | — | — | US | disclosed |
| US-20150210630-A1 | OXIME-SUBSTITUTED AMIDE COMPOUND AND PEST CONTROL AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-07-30 | — | — | US | disclosed |
| EP-2873658-A1 | OXIME-SUBSTITUTED AMIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2015-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160318919-A1 | OXIME-SUBSTITUTED AMIDE COMPOUND AND PEST CONTROL AGENT | CHRM1, CHRM2, CHRM4 | LMNA 3021/4885GAA 4209/4885ALDH1A1 3899/4885 |
| US-20150210630-A1 | OXIME-SUBSTITUTED AMIDE COMPOUND AND PEST CONTROL AGENT | CHRM1, CHRM2, CHRM4 | LMNA 3021/4885GAA 4209/4885ALDH1A1 3899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.